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We recently report that the expression of polycomb chromobox 4 (Cbx4) is significantly correlated with the overall survival of 
a great cohort of hepatocellular carcinoma (HCC) patients and it enhances hypoxia-induced vascular endothelial growth factor 
(VEGF) expression and angiogenesis in HCC cells through enhancing sumoylation of hypoxia inducible factor-1alpha 
(HIF-1α). Here we continue to investigate the potential effects of Cbx4 on the migration and metastasis of the metastatic HCC 
cell line MHCC97L. Our results show that Cbx4 overexpression in the cell line increases the in vitro vessel formation of vas-
cular endothelial cells in its SUMO interaction motifs-dependent manner, and promotes the in vitro migration of the cancer cell, 
which can be effectively abrogated by anti-VEGF antibody. Although Cbx4 expression does not impact the in vitro growth of 
MHCC97L cells, it still promotes the progression and metastasis of orthotopically transplanted tumors in nude mice. These re-
sults further support the role of Cbx4 as a SUMO E3 ligase in the progression and metastasis of HCC. 
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Polycomb group proteins (PcG), a set of transcriptional re-
pressors which impose the histone H3 lysine 27 
tri-methylation for repression of gene expression [1,2], as-
semble into at least two major classes of multimeric protein 
polycomb repressive complexes (PRC) in mammal, that is, 
PRC1 and PRC2. They are essential for embryonic devel-
opment and stem cell renewal and contribute widely to a 
series of biological processes such as cell cycle, DNA repair, 
cell differentiation, senescence and death [1,35]. Accord-
ingly, the increasing lines of evidence demonstrate that 
dys-regulations of genes encoding PcG proteins, such as 
Bmi1, Cbx7 and Ezh2 are associated with tumorigenesis of 
many kinds of cancers [68]. 
Like other members of the Cbx family, polycomb chro-
mobox (Cbx) protein 4 (Cbx4, also designated as polycomb 
2, Pc2) can bind to methylated histones as an important 
component for PRC1 [9]. However, Cbx4 but not other 
members of Cbx family has also been reported to act as the 
small ubiquitin-related modifier (SUMO) E3 ligase, which 
can enhance the sumoylation of transcriptional co-repressor 
C terminal binding protein (CtBP) [10], Smad-interacting 
protein 1 (SIP1) [11], DNA methyltransferase 3a (Dnmt3a) 
[12], multifunctional Ca2+-binding protein centrin-2 [13] 
and homeodomain-interacting protein kinase 2 (HIPK2) 
[14]. Structural analyses reveal that the N-terminal chro-
modomain and two SUMO interaction motifs (SIM1 and 
SIM2) appear to be required for its repressor and SUMO E3 
ligase activity, respectively [1518].  
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More recently, we reported that Cbx4 expression is sig-
nificantly correlated with the overall survival of a great co-
hort of hepatocellular carcinoma (HCC) patients and of 
subcutaneously and orthotopically transplanted HCC mice 
[17]. Further, Cbx4 enhances hypoxia-induced vascular 
endothelial growth factor (VEGF) expression and angio-
genesis in HCC cell lines such as SMMC-7721, HepG-2, 
BEL-7402 and MHCC97L [17]. Mechanically, Cbx4 en-
hances sumoylations of hypoxia inducible factor-1alpha 
(HIF-1α) protein, thus increasing the transcriptional activity 
of HIF-1 in its SUMO E3 ligase activity-dependent mecha-
nisms [17,18]. Here we continue to investigate the potential 
effects of Cbx4 on the migration and metastasis of 
MHCC97L, a metastatic HCC cell line [19]. 
1  Materials and methods 
1.1  Cell culture and transfection 
293T cells were obtained from Cell Resource Center of 
Shanghai Institute for Biological Science, Chinese Acade-
my of Sciences (Shanghai, China). Dr. Qing LunXiu at Fu-
dan University (Shanghai, China) and Dr. Yi ZhengFang at 
East China Normal University (Shanghai, China) provided 
us MHCC97L [19] and human umbilical vascular endothe-
lial cells (HUVEC) respectively. 293T cells and MHCC97L 
cells were cultured in DMEM containing 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin. HUVEC cells 
were maintained in ECM containing 10% FBS. Hypoxic 
condition was performed in a specially designed hypoxic 
incubator (Thermo Electron, Forma, USA) with 1% O2, 
94% N2 and 5% CO2. Lipofectamine 2000 transfection rea-
gent (Invitrogen, USA) was used for transient transfection. 
Transient co-transfection with helper plasmids was per-
formed into 293T cells to prepare retroviruses. Cells were 
infected at approximately 70% density in DMEM supple-
mented with 8 g mL1 of polybrene. Twenty-four hours 
later, DMEM medium containing 10% FBS and 1 g mL1 
puromycin was added to select stable cell lines, as we de-
scribed previously [17]. 
1.2  Plasmid construction 
Cbx4-expressing pCMV plasmids with amino-terminal Flag 
tag were generously provided by Dr. Weng JieMin at East 
China Normal University (Shanghai, China). Flag-tagged 
Cbx4 mutants were constructed by using QuikChangeTM 
Lightning Site-Directed Mutagenesis Kit (Stratagene, USA). 
Flag-Cbx4 and its mutants were cloned into pBABE puro 
vector (Cell Biolabs, Inc., USA) for stable transfection as 
described previously [17]. 
1.3  In vitro tube formation  
According to the manufacturer’s instructions, the Matrigel 
was placed in a refrigerator at 4°C overnight to thaw. Once 
it had thawed, 24-well plates were coated with 100 L/well 
of Matrigel (BD Biosciences, USA) and immediately placed 
in an incubator at 37°C for 1 h. HUVEC (2104) in 1 mL of 
conditional DMEM medium, which had been incubated 
with 1.5105 MHCC97L cells for 48 h, were seeded onto 
the solidified gel. After incubating in an atmosphere of 5% 
CO2 and 95% air at 37°C for 16 h to allow the formation of 
a capillary-like structure, the endothelial tubes were counted 
under photomicroscope at 200× magnification over five 
fields in each slide. 
1.4  Immunohistological chemistry staining 
Sections were stained with anti-Cbx4 (dilution 1:25, SC- 
19299, USA) and anti-VEGF polyclonal antibody (dilution 
1:500, SC-152, USA) to analyze their protein levels. All 
responses were followed by staining with the corresponding 
HRP-conjugated secondary antibody (KIT-9719 and KIT- 
9707, Maixin Biotechnology, China). Images were captured 
by Nikon Ti-S microscope equipped with a digital camera 
system (Nikon). 
1.5  Cell counting Kit-8 (CCK8) assay 
MHCC97L cells were plated in 96-well plates at the density 
of 1000 cells per well with 100 μL of complete culture me-
dium. After adhesion for 24 h, the cells were cultured for 
additional 24, 48, 72, 96 and 120 h. The wells only with the 
culture medium were used as blank controls. At each time 
point, the supernatant was removed and 100 μL of DMEM 
medium containing 10 μL of CCK8 (Dojindo, Japan) was 
added to each well for additional 3 h at 37°C. The absorb-
ance was recorded at 450 nm. All experiments were inde-
pendently repeated at least three times. 
1.6  Flow cytometry analysis 
To analyze cellular DNA content by flow cytometry, 1106 
cells were collected, rinsed and fixed overnight with 75% 
cold ethanol at 20°C. Cells were then treated with 100 μg 
mL1 RNase A in Tris-HCl buffer (pH 7.4) and stained with 
25 μg mL1 propidium iodide (PI, Sigma-Aldrich, USA). 
Samples were then subjected to the analysis by flow cytom-
etry (FACSCalibur, BD Biosciences, USA) using CellQuest 
Pro software (BD Biosciences). Ten thousand cells were 
acquired and analyzed for the DNA content. 
1.7  Migration assay 
The MHCC97L cells (1.5×105 cells per 100 μL) in serum 
and insulin-free DMEM with or without anti-VEGF anti-
body were seeded on 8-μm pore transwell inserts (Corning 
Costar No. 3422; Corning, USA). After 24 h, cells on the 
upper side of the inserts were removed with a cotton swab. 
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For evaluation of cells that migrated onto the lower surface, 
inserts were fixed in 4% paraformaldehyde for 15 min and 
dyed in 0.1% crystal violet for 45 min. The transwell mem-
branes were then removed, placed on a glass slide with the 
side containing cells facing up, overlaid with a cover slip 
(VWR® Micro Cover Glasses, Round, No. 1). Migrated 
cells were counted in five non-overlapping locations, which 
covered approximately 70% of the insert membrane growth 
area, using a Nikon Ti-S microscope equipped with a digital 
camera system (Nikon). The experiment was repeated at 
least three times. 
1.8  Western blot 
Protein extracts were quantified and separated by 10% 
SDS-polyacrylamide gel, and transferred to the Immobi-
lon™PVDF Transfer Membranes (Millipore Corporation, 
USA). After blocking with 5% nonfat milk in PBS, mem-
branes were immunoblotted with anti-Flag antibody (F1804, 
Sigma, Germany) together with anti--actin antibody 
(Merck, Germany) as the internal control. Then horseradish 
peroxidase (HRP)-linked secondary antibody (Cell Signal-
ing, USA) was incubated for 1 h at room temperature. The 
signals were detected by ImmobilonTM Western Chemi-
luminscent HRP Substrate kit (Millipore Corporation).  
1.9  Animal experiments 
GFP-Luciferase-labeled MHCC97L cells (3×106) suspended 
in 40 µL of DMEM/Matrigel (1:1) were orthotopically in-
oculated into the left hepatic lobe of six-week-old male 
BALB/c nude mice under anesthesia, which were obtained 
from Shanghai SLAC Laboratory Animal Co. (China). 
Anesthetized mice were retroorbitally injected with 75 mg 
kg1 D-Luciferin (360202, CellCyto), and the photon fluxes 
(photons per second) emitted from tumor cells was moni-
tored by bioluminescent images (BLI). Bioluminescence 
images were acquired with the IVIS Imaging System 
(Xenogen, USA). Analysis was performed with Living Im-
age software (Xenogen) by measuring photon flux of the 
upper abdominal and thoracic region. Data were normalized 
to the signal obtained immediately after injection (day 0). 
At day 35, mice were sacrificed. All livers and lungs were 
dissected, fixed with phosphate-buffered neutral formalin, 
paraffin-embedded and cut in slices. 
All animals were handled in strict accordance to the 
“Guide for the Care and Use of Laboratory Animals” and 
the “Principles for the Utilization and Care of Vertebrate 
Animals”, and all animal work was approved by the Institu-
tional Animal Care and Use Committee at the Shanghai Jiao 
Tong University School of Medicine. 
1.10  Statistical analysis 
The P values for comparison between line-linked groups  
were obtained by student’s t-test. All statistical tests were 
two-sided, and P<0.05 were considered to be statistically 
significant. 
2  Results 
2.1  Cbx4 increases in vitro vessel formation in its 
SIMs-dependent manner 
As we previously mentioned [17], Cbx4 enhances hypox-
ia-incubated HCC cell lines including MHCC97L cells to 
produce VEGF, a master stimulator of angiogenesis and 
vascular permeability in cancer tissues [20]. Thus, we de-
tected whether Cbx4 affects the in vitro vessel formation in 
the co-culture system of HUVEC and MHCC97L cells with 
or without ectopic stable expression of Flag-tagged wild- 
type Cbx4 (Cbx4-WT), Cbx4-CDM or Cbx4-SIM1/2 
(Figure 1A), in which Cbx4-CDM mutant carries F11A/ 
W35L double-mutation in its chromodomain of Cbx4 and 
loses its polycomb function but still presents SUMO E3 
ligase activity, while Cbx4-SIM1/2 mutant is absent of 
their two SIMs and lose SUMO E3 ligase activity [17]. In 
line with those seen in HCC cell line SMMC-7721 [17], 
overexpression of Cbx4-WT and Cbx4-CDM in MHCC97L 
cells also increased the vessel formation of HUVEC. How-
ever, such an effect could not be seen in the Cbx4-SIM1/2 
mutant-expressing cells (Figure 1B and C). 
2.2  Cbx4 promotes the migration of MHCC97L cells 
by increasing VEGF 
It has been known that VEGF-mediated signaling in cancer 
is not limited to angiogenesis, and also contributes to other 
key aspects of tumorigenesis such as tumor metastasis 
[20,21]. Therefore, we tested the potential effects of Cbx4 
and its mutants on the migration of MHCC97L cells by 
transwell experiments. Our results showed that hypoxia but 
not normoxia increased migration of MHCC97L cells, 
which was significantly enhanced by overexpressions of 
Cbx4-WT and Cbx4-CDM but not Cbx4-SIM1/2 (Figure 
2), suggesting that Cbx4 promotes the hypoxia-induced mi-
gration of cancer cells, which is also dependent on its SIMs 
domains.  
To determine whether the increased VEGF under hypox-
ia contributes to the enhanced migration of MHCC97L cell 
with stable ectopic Cbx4-WT and Cbx4-CDM expression, 
we treated these cells together with anti-VEGF antibody to 
neutralize VEGF under hypoxia and normoxia, followed by 
the transwell experiments. The results showed that an-
ti-VEGF antibody almost completely inhibited the hypox-
ia-stimulated migration of MHCC97L cells in spite of the 
expressions of Cbx4-WT, Cbx4-CDM or Cbx4-SIM1/2 
(Figure 2). All these results indicate that Cbx4-promoting 
migration of MHCC97L cells is mediated by the increased 
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Figure 1  Cbx4 overexpression in MHCC97L cells increases hypoxia-induced in vitro tube formation of HUVEC. A, Western blots for the indicated 
flag-tagged proteins with -actin as a loading control in the lysates from MHCC97L cells ectopically expressing the vehicle or flag-tagged Cbx4-WT or its 
mutants. B, Photographs for the endothelial tubes in co-culture of MHCC97L cells stably expressing the flag-tagged genes as indicated together with 
HUVEC under normoxia or hypoxia for 16 h. C, The number of the endothelial tubes formed by HUVEC in the co-culture assay, together with MHCC97L 
cells stably expressing the genes as indicated under normoxia or hypoxia for 16 h. Data are mean±SD in triplicates in an independent experiment, which was 
repeated at least three times with the same results. 
VEGF expression.  
2.3  Cbx4 fails to regulate growth and cell cycle pro-
gression of MHCC97L cells 
Previously, we reported that Cbx4 did not affect cell growth 
of HCC cells under normoxia [17]. Here we further showed 
that ectopic expressions of Cbx4 and its two mutants did not 
significantly interfere with the growth of MHCC97L cells 
under hypoxia (Figure 3A). Furthermore, we analyzed the 
cell cycle distribution in these MHCC97L with or without 
overexpression of Cbx4 and its mutants. The results also 
support that Cbx4 and its mutants did not regulate cell cycle 
progression of the HCC cell line under either normoxia 
(Figure 3B) or hypoxia (Figure 3C). 
2.4  Cbx4 enhances the in vivo growth of MHCC97L 
cell-transplanted tumors 
Although Cbx4 expression did not impact the in vitro 
growth of MHCC97L cells, we still directly injected 
GFP-luciferase-labeled MHCC97L cells expressing vehicle, 
Cbx4-WT, Cbx4-CDM and Cbx4-SIM1/2 into the livers 
of BALB/c nude mice, followed by monitoring luciferase 
photon fluxes each week. The results demonstrated that like 
those in SMMC-7721 cells [17], fluorescence intensities of 
tumors with ectopic expressions of Cbx4-WT and Cbx4- 
CDM were greatly higher than those of vehicle and Cbx4- 
SIM1/2 (Figure 4A). The representative noninvasive BLI 
at the 5th week after orthotopical injection are shown (Fig-
ure 4B). Then, we executed and dissected the nude mice in 
the 5th week post-transplantation. As depicted in Figure 4C, 
liver tumors with Cbx4-WT and Cbx4-CDM overexpres-
sions were much bigger and more widely distributed in liv-
ers than those with vehicle and Cbx4-SIM1/2-express- ing 
cells. In line with the notion, nude mice transplanted with 
Cbx4-WT and Cbx4-CDM but not Cbx4-SIM1/2 had 
more numbers of tumor nodules in livers (Figure 4D). As 
consistent with our previous report in HCC cell line 
SMMC-7721 cells [17], additionally, Cbx4 and Cbx4-CDM 
but not Cbx4-SIM1/2 expressions remarkably increased 
VEGF expression in the transplanted tumors, as estimated 
by immunohistochemical staining (Figure 4E).
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Figure 2  Cbx4 promotes VEGF-mediated in vitro migration of MHCC97L cell. A, Images of cell migration were obtained by capturing migrated 
Flag-tagged Cbx4, its mutants or vehicle-infected MHCC97L cells on uncoated membranes of transwell chambers after 24 h. B, Numbers of migrated cells 
were assessed by counting migrated MHCC97L cells on uncoated membranes. Data are mean±SD in triplicates in an independent experiment, which was 
repeated at least for three times with the same results. 
2.5  Cbx4 promotes the metastasis of MHCC97L cells 
in vivo 
Based on our observation that Cbx4 and Cbx4-CDM ex-
pression remarkably increased the in vitro migration of 
MHCC97L cells under hypoxia (Figure 2), we also ob-
served the potential tumors in other tissues besides livers. 
The results showed that there was a higher frequency of 
pulmonary metastasis and the more tumor nodule numbers 
in lungs of the nude mice injected with MHCC97L cells 
stably expressed Cbx4-WT and Cbx4-CDM than vehicle 
and Cbx4-SIM1/2 (Figure 5A). A representative image for 
lung metastasis from nude mice with the transplantation of 
Cbx4-expressing MHCC97L cells is shown in Figure 5B. 
All these results support that like SMMC7721 cells previ-
ously reported [17], Cbx4 but not its SUMO E3 ligase ac-
tivity-absent Cbx4-SIM1/2 could promote in vivo metasta-
sis of MHCC97L cells. 
3  Discussion 
Hepatocellular carcinoma is one of the most common can-
cers worldwide, with an increasing incidence in Asian and 
also in Western countries as a result of increasing hepatitis 
B and hepatitis C virus infection [22]. More than 80% of 
patients with HCC have been associated with cirrhosis and 
impaired liver function, making treatment of HCC more 
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Figure 3  Cbx4 has no effect on proliferation and cell cycle progression of MHCC97L cells. A, MHCC97L cells ectopically expressing Flag-tagged 
Cbx4-WT and its mutants were incubated under hypoxia for the indicated days. The growth rates were measured by CCK8 assay normalized to vehicle cells 
at 0 h. B and C, MHCC97L cells transfected with Flag-tagged Cbx4-WT and its mutants were incubated under normoxia or hypoxia for 48 h, followed by 
flow cytometric analysis for DNA distribution. The percentage of cells at each stage of cell cycle was quantified. All these experiments were repeated for at 
least three times with the same results. 
difficult than many other cancers. HCC is a hypervascular 
tumor characterized by neovascularization, which plays an 
important role in the growth and progression of HCC. 
Therefore, it is proposed that angiogenesis provides a target 
for novel prognostic and therapeutic approaches to HCC 
[23,24]. Currently, available antiangiogenic cancer chemo-
therapy targeting the VEGF pathway by monoclonal an-
ti-VEGF antibody bevacizumab or multi-targeted receptor 
tyrosine kinase inhibitors such as sorafenib has emerged 
[25,26]. On the other hand, HIF-1 induces expression of 
angiogenic growth factors such as VEGF, stromal derived 
factor 1, angiopoietin 2, platelet-derived growth factor B 
and stem cell factor. Therefore, it is a key regulatory factor 
for angiogenesis in response to hypoxia and plays an im-
portant role in the pathogenesis of cancers including HCC, 
suggesting the possibility of HIF-1α as a novel therapeutic 
target in HCC [27]. More recently, we reported that Cbx4 
governs HIF-1α to increase VEGF production and thus po-
tentiate angiogenesis of HCC by its SUMO E3 ligase activ-
ity [17]. Because VEGF also contributes to other oncogene-
sis events besides angiogenesis [20,21,28], here we investi-
gate the potential impacts of Cbx4 on migration and metas-
tasis of HCC cell line MHCC97L. We demonstrate that the 
overexpression of Cbx4 but not its SUMO E3 ligase activi-
ty-absent mutant in MHCC97L increases in vitro hypox-
ia-stimulated vessel formation of HUVEC, which is con-
sistent with our previous observation that Cbx4 enhances 
VEGF production in the HCC cell line SMMC-7721 [17]. 
More interestingly, we also find that Cbx4 promotes the 
migration on transwell of MHCC97L cells under hypoxia 
but not normoxia, for which its SIMs are necessary. Espe-
cially, anti-VEGF antibody almost completely inhibits mi-
gration-enhancing effect of Cbx4, indicating that this event 
is mediated by the increased VEGF expression.  
It was reported that targeted disruption of Cbx4 causes 
severe hypoplasia of the fetal thymus as a result of reduced 
thymocyte proliferation [29]. Cbx4 was also shown to 
maintain human epidermal stem cells as slow-cycling and 
undifferentiated, and inhibit stem cell activation and differ-
entiation through its SUMO ligase activity [30]. More re-
cently, it was also reported that Cbx4 knockdown led to the 
decreased proliferation and impaired cell cycle progression 
in HCC cell lines [31]. However, our results show that Cbx4 
fails to regulate growth and cell cycle progression of 
MHCC97L cells under either hypoxia or normoxia. In  
spite of this, tumors from subcutaneously transplanted  
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Figure 4  Cbx4 enhances in vivo progression of tumors injected with MHCC97L cells. GFP-luciferase-labeled Cbx4-WT and its mutants-infected 
MHCC97L cells were orthotopically injected into livers. A, The photon fluxes (photons per second) were monitored by bioluminescence imaging using 
Xenogen imaging system at the indicated weeks post injection. B, Four representative noninvasive BLI at day 35 after injection with the color scale depicting 
the photon fluxes emitted from the tumor cells. C, Four representative macroscopic observations of removed livers at day 35 post injection. D, The numbers 
of tumor nodules in the liver under microscope at day 35 post injection. E, The representative IHC staining images (scale bars, 100 m) of Cbx4 and VEGF 
in MHCC97L cells-originated tumors at day 35 post injection. Data are mean±SEM (A) or mean±SD (D) of mice in the numbers indicated in the parenthesis. 
 
Figure 5  Cbx4 promotes in vivo metastasis of MHCC97L cells. A, The number of lung metastasis nodules under microscope at day 35 post injection. Data 
are mean±SD of mice in the number indicated in the parenthesis. B, A representative hematoxylin and eosin staining image of lung metastasis nodule 
(rounding by black line) from Cbx4-expressing cells.  
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SMMC7721 and MHCC97L cell lines with the overexpres-
sion of Cbx4-WT and CDM mutant but not SIM1/2 mu-
tant grew more rapidly compared with vehicle controls [17]. 
Here we further reveal that tumors from orthotopically 
transplanted MHCC97L cell lines with the overexpression 
of Cbx4 but not SIM1/2 mutant also grew more rapidly, as 
seen in orthotopically transplanted SMMC-7721 cells [17]. 
Of great importance, these orthotopically transplanted 
MHCC97L cells with Cbx4 overexpression present signifi-
cantly higher ability of pulmonary metastasis.  
Taken together, our results further support that Cbx4 
plays an extremely important role in the process of progres-
sion and metastasis of HCC through its SUMO E3 ligase 
activity. Therefore, to explore the agents to target SUMO 
E3 ligase activity of Cbx4 might be of great significance for 
the treatment of HCC patients.   
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